Company Filing History:
1 out of 346 
1 out of 2 Years Active: 1988
Title: The Innovative Contributions of Sara Ronai nee Lukacs
Introduction
Sara Ronai, nee Lukacs, is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, with a particular focus on anticonvulsive medications. Her innovative approach has led to the development of novel compounds that provide effective treatment options for patients suffering from seizures.
Latest Patents
Sara Ronai holds a patent for "Novel anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives." This invention relates to optically active or racemic tetrahydro-1,2,4-oxadiazine-5-thione derivatives and methods for their preparation. The pharmaceutical compositions derived from these compounds serve as active ingredients in anticonvulsive treatments for mammals, especially humans. Remarkably, these compounds exhibit efficacy comparable to diphenyl hydantoine with significantly lower toxicity.
Career Highlights
Throughout her career, Sara has worked with notable organizations in the field of chemistry. She has been associated with Richter Gedeon Vegyészeti Gyár Rt, where she contributed her expertise to the pharmaceutical industry. Additionally, her tenure at MTA Központi Kemiai Kutató Intezet further exemplifies her commitment to research and innovation in chemical sciences.
Collaborations
Sara's collaborative efforts with colleagues such as Csilla Vezért, nee Solyom, and László Rogdi have played a pivotal role in advancing her research initiatives. Working alongside talented professionals has allowed her to enhance the scope of her inventions and foster a collaborative spirit in the research community.
Conclusion
Sara Ronai, nee Lukacs, stands out as an influential inventor in the realm of pharmaceutical chemistry. Her development of novel anticonvulsive compounds has the potential to transform treatment methods for patients with seizure disorders. Through her dedication and collaboration, she continues to pave the way for innovative breakthroughs in medicine.